Health Treating substance use disorders via telemedicine: barriers and reforms Daniel Zinsmaster, Dinsmore & Shohl, LLP, Columbus, OH and Margaret Power, Dinsmore & Shohl, LLP, Morgantown, WV On October 26, 2017, the opioid epidemic was officially declared a national public health emergency by the United States Department of Health and Human Services (HHS).
Health The Travel Act: sixty-year old “new” tool in healthcare fraud enforcement Patrick D. Souter, Gray Reed & McGraw LLP, Dallas, TX It is undisputed that a major hurdle in being able to provide the financial resources necessary to deliver quality healthcare in the United States is the amount of fraud prevalent in the industry.
Health The DOJ’s Granston memo encourages dismissal of meritless qui tam cases Gerald L. Aben, Dykema, Ann Arbor, MI and Lea Courington, Dykema, Dallas, TX A recent memorandum (Memo) issued by the United States Department of Justice (DOJ) to attorneys in the Commercial Litigation Branch, Civil Fraud Section suggests that the DOJ may be adopting a more assertive attitude with regards to dismissal of False Claims Act (FCA) qui tam cases.
Health You’ve got patients! A case study in fair market value and commercial reasonableness: considerations for attorneys evaluating telemedicine arrangements Luis Argueso, HealthCare Appraisers, Inc. Denver, CO On February 9, 2018, President Trump signed into law the Bipartisan Budget Act of 20181 passed by Congress. It incorporated the text of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act.2